Home
About
Overview
Sharing Data
ORCID
Help
History (19)
Principal Investigator
Relationship between amikacin blood concentration and ototoxicity in low birth weight infants.
Principal Investigator
Adults with cerebral palsy and chronic pain experience: A cross-sectional analysis of patient-reported outcomes from a novel North American registry.
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC.
See All 19 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Philipson, Louis
One or more keywords matched the following items that are connected to
Philipson, Louis
Item Type
Name
Concept
Glucagon-Like Peptide 1
Academic Article
Regulation of cAMP dynamics by Ca2+ and G protein-coupled receptors in the pancreatic beta-cell: a computational approach.
Academic Article
SUMO downregulates GLP-1-stimulated cAMP generation and insulin secretion.
Academic Article
Intragranular targeting of syncollin, but not a syncollinGFP chimera, inhibits regulated insulin exocytosis in pancreatic beta-cells.
Academic Article
Type 2 diabetes and congenital hyperinsulinism cause DNA double-strand breaks and p53 activity in ß cells.
Academic Article
Chronic hyperglycemia downregulates GLP-1 receptor signaling in pancreatic ß-cells via protein kinase A.
Academic Article
The role of ß cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs.
Academic Article
The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis.
Academic Article
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study.
Concept
Glucagon-Like Peptide-1 Receptor
Academic Article
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists.
Search Criteria
Glucagon Like Peptide 1